Factors associated with long length of stay in an inpatient psychiatric unit in Lilongwe, Malawi.
Malawi
Mental disorders
Mental health
Psychiatry
Sub-Saharan Africa
Journal
Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
01
04
2018
accepted:
08
10
2018
pubmed:
24
10
2018
medline:
15
5
2019
entrez:
24
10
2018
Statut:
ppublish
Résumé
Studies of factors affecting length of stay during psychiatric hospitalization in sub-Saharan Africa are sparse. A better understanding of such factors may lead to interventions resulting in quicker patient stabilization and discharge, freeing up needed psychiatric beds and reducing health care system expenditures. Therefore, we sought to identify factors associated with long length of stay in Malawi. We reviewed the charts of 417 patients hospitalized at Kamuzu Central Hospital's Bwaila Psychiatric Unit in Lilongwe, Malawi from January 1 to December 31, 2011. Multivariate logistic regression analysis was employed to test for associations between patient factors and long length of stay (defined as more than 28 days). Mean length of stay was 22.08 ± 27.70 days (range 0-243). 21.82% (91/417) of patients stayed longer than 28 days. Long length of stay was associated with living outside of Lilongwe district [aOR: 3.65 (1.66-8.01), p = 0.001] and treatment for antipsychotic extrapyramidal side effects (EPS) during hospitalization [aOR: 3.45 (1.32-9.03), p = 0.012]. Patients who had more interactions with medical providers for this episode of illness prior to presentation at the unit were less likely to have a long length of stay [aOR: 0.35 (0.16-0.76), p = 0.008]. Our findings demonstrate areas of possible intervention to reduce length of stay, including securing means for patient transport home, rapid identification and treatment of EPS, and reducing the risk of EPS by decreased use of high potency first-generation antipsychotics.
Identifiants
pubmed: 30349960
doi: 10.1007/s00127-018-1611-1
pii: 10.1007/s00127-018-1611-1
pmc: PMC6586467
mid: NIHMS1524780
doi:
Substances chimiques
Antipsychotic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
235-242Subventions
Organisme : National Institutes of Health
ID : P30 AI50410
Organisme : National Institutes of Health
ID : D43TW010060
Organisme : National Institute of Mental Health
ID : K01MH100428
Organisme : FIC NIH HHS
ID : R24 TW007988
Pays : United States
Organisme : Fogarty International Center
ID : R24TW007988
Organisme : FIC NIH HHS
ID : D43 TW010060
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH100428
Pays : United States
Organisme : African Mental Health Research Initiative
ID : DEL-15-01
Organisme : NIAID NIH HHS
ID : P30 AI050410
Pays : United States
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Int J Psychiatry Clin Pract. 2015;19(4):238-44
pubmed: 26073671
Afr J Med Med Sci. 2012 Jun;41(2):147-52
pubmed: 23185912
Adm Policy Ment Health. 2011 May;38(3):155-68
pubmed: 20924662
Bull World Health Organ. 2015 Aug 1;93(8):516
pubmed: 26677469
Aust N Z J Psychiatry. 2011 Jul;45(7):578-85
pubmed: 21718126
Afr J Psychiatry (Johannesbg). 2008 May;11(2):128-32
pubmed: 19582331
Psychiatry (Edgmont). 2005 Mar;2(3):36-41
pubmed: 21179628
Turk Psikiyatri Derg. 2009 Spring;20(1):49-55
pubmed: 19306126
Am J Psychiatry. 1991 Nov;148(11):1558-61
pubmed: 1681751
Int J Cult Ment Health. 2018;11(4):574-582
pubmed: 32863863
Braz J Psychiatry. 2010 Jun;32(2):145-51
pubmed: 20027489
Int J Ment Health Syst. 2015 Mar 10;9:13
pubmed: 25780386
BMC Psychiatry. 2016 Nov 7;16(1):376
pubmed: 27821155
Psychiatr Serv. 2012 Sep 1;63(9):889-95
pubmed: 22751995